Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study
Authors:
- 29 November 2014
- journal article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 37 (1) , 86-93
Abstract
Background Nebulised medicines contribute to the high treatment burden experienced by patients with cystic fibrosis (CF). Objectives This study explored experiences of adult patients with CF when using nebulised medicines, factors impacting on their adherence to nebulised therapy and strategies they used to facilitate adherence. Setting Community setting, in Sydney, Australia. Methods Ten patients with CF were recruited through a CF patient organisation. Semi-structured face-to-face interviews were conducted, addressing the study objectives. Interviews were audio-recorded, transcribed verbatim and content analysed for anticipated and emergent themes. Main outcome measure Experiences with using nebulised medicines; and barriers and facilitators of adherence to nebulised medicines. Results Participants’ age ranged from 22 to 45 years, with half being male. Four broad themes (with more specific sub-themes) were identified from the interviews: experiences with using nebulised medicines (cleaning nebuliser, time taken to use nebuliser medicine, flexibility in use of nebuliser); feelings about using nebulised medicines (necessary/important, dislike, part of life); factors impacting non-adherence (time consuming therapy, side effects/effects of medicine, work/social demands, lack of perceived importance); factors and strategies facilitating adherence (perceived medicine importance, habit/routine, support, health benefits, technology/medicine dose form, timetabling). Conclusions Nebulised therapy for cystic fibrosis patients takes a substantial amount of time, with patients trying to alter their routine to incorporate nebulising into their daily lives. However there are still many factors that lead to low adherence, including work/social demands and travelling. Patients balance the necessity for nebulised therapy against the barriers, and engage in intentional non-adherence at times. Future strategies and resources should target and address specific factors identified by patients with CF as being important and impacting their adherence to nebulised medicines.Keywords
This publication has 27 references indexed in Scilit:
- Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parentsPatient Preference and Adherence, 2011
- Longitudinal association between medication adherence and lung health in people with cystic fibrosisJournal of Cystic Fibrosis, 2011
- Adherence with tobramycin inhaled solution and health care utilizationBMC Pulmonary Medicine, 2011
- Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosisPediatric Pulmonology, 2010
- High treatment burden in adults with cystic fibrosis: Challenges to disease self-managementJournal of Cystic Fibrosis, 2009
- Update in Cystic Fibrosis 2007American Journal of Respiratory and Critical Care Medicine, 2008
- Cystic Fibrosis Pulmonary GuidelinesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?Journal of Pediatric Psychology, 2006
- So Many Drugs, So Little TimeChest, 2003
- Nebulised dornase alpha: adherence in adults with cystic fibrosisJournal of Cystic Fibrosis, 2002